Personalized medicine – also referred to as individualized or precision medicine – is a field of research which aims to map out genomes or genetic markers of individual patients to develop personalize

سیر تکاملی پزشکی شخصی:
چگونه در طی زمان دانشمندان به شباهتها و تفاوتهای ژنوم دست پیدا کردند.
انسانها ۹۹% تشابه در ژنها دارند، با این حال بیماریها مخصوصا سرطان، در انسانها منحصر بفرد است.

بررسی مولکولها برای شخصی کردن پزشکی در قاره های متفاوت

نرم افزارهای پزشکی شخصی:
ابر نرم افزارهایی که قادرند "بیان متفاوت یک ژن" را برای سلولهای متفاوت ترسیم کنند.

The field of personalized medicine has made significant progress with key discoveries like single nucleotide polymorphism and microarray/biochips. These advances will benefit plans, patients, the pharmaceutical industry, and society.

Immunohistochemistry in the era of personalised medicine.

Immunohistochemistry (IHC) plays a central role in the histopathological classification of diseases, including cancer. More recently, the importance of immunohistochemical staining is increasing. IHC usage in diagnostics is invaluable; however, the genetic and therapeutic significance of biomarker immunostaining has become equally relevant.

CONTENT:

In this article, we would like to analyse the three distinct roles of IHC and review their individual impacts on modern diagnostic pathology: (1) diagnostic IHC; (2) genetic IHC and (3) therapeutic IHC.

SUMMARY:

Thus, we will characterise the different analytical processes that are required in the three approaches to IHC usage stated above, as well as the clinical significance and overall importance in patient management. This will allow us to hypothesise on the most appropriate laboratory environment and detection methods for the future.

تجربیات کودکی DNA را تغیر می دهد.
نتایج تحقیقات جدید نشان می‌دهد که این تجربیات اولیه زندگی توانایی تغییر بدن در سطح ژنتیکی را دارد.